Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-29

Clinical Trial Update: XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating XS005 injections with the Stupp regimen for adjuvant chemotherapy in patients with primary glioblastoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XS005

Snippet

Sponsor: Dushu Lake Hospital Affiliated to Soochow University | Conditions: Tumor | Phase 1, Phase 2 | Status: SUSPENDED